MSL
CCXI

Mackay Shields LLC’s ChemoCentryx, Inc. CCXI Stock Holding History

Mackay Shields LLC’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-19,800
Closed -$1.01M – 1438
2021
Q1 		$1.01M Sell
19,800
-13,200
-40% -$794K 0.01% 990
2020
Q4 		$2.04M Buy
33,000
+1,700
+5% +$97.3K 0.01% 847
2020
Q3 		$1.72M Sell
31,300
-4,500
-13% -$242K 0.01% 852
2020
Q2 		$2.06M Buy
35,800
+6,600
+23% +$359K 0.02% 742
2020
Q1 		$1.17M Buy
+29,200
New +$1.24M 0.01% 893

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mackay Shields LLC's CCXI Position: Q2 2021 in Review

Mackay Shields LLC sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 19,800 shares — an estimated $1.01M sold.

Mackay Shields LLC first reported a position in CCXI in Q1 2020 and held it in 5 quarters. The position peaked at $2.06M in Q2 2020. 146 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

  • Mackay Shields LLC reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 19,800 ChemoCentryx, Inc. shares in Q2 2021, an estimated $1.01M.
  • Mackay Shields LLC first reported a position in ChemoCentryx, Inc. in Q1 2020 and held it in 5 quarters.
  • Mackay Shields LLC's ChemoCentryx, Inc. position peaked at $2.06M in Q2 2020.
  • 146 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.